Novo Nordisk A/S annual revenue for fiscal TTM was DKK 329.4 billion, an increase of 6.6% from DKK 309.1 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Revenue (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | DKK 329.4B | DKK 309.1B | DKK 290.4B | DKK 232.3B | DKK 177.0B | DKK 140.8B | DKK 126.9B | DKK 122.0B | DKK 111.8B | DKK 111.7B | DKK 111.8B | DKK 107.9B | DKK 88.8B | DKK 83.6B | DKK 78.0B | DKK 66.3B | DKK 60.8B | DKK 51.1B | DKK 45.7B | DKK 41.9B | DKK 38.8B |
DKK; DKKM / DKKB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Revenue (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | DKK 78.5B | DKK 96.8B | DKK 79.1B | DKK 75.0B | DKK 76.9B | DKK 78.1B | DKK 85.7B | DKK 71.3B | DKK 68.1B |
DKK; DKKM / DKKB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More NVO metrics: Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All NVO financial statements → Interactive NVO charts →
About TickerBase · Data methodology & sources · Privacy · Terms